Citations 1
Pevonedistat with azacitidine in older patients with TP53-mutated AML: a phase 2 study with laboratory correlates
Saliba, Antoine N. , Kaufmann, Scott H. , Stein, Eytan M. , Patel, Prapti A. , Baer, Maria R. , Deininger, Michael W. , Blum, William , Schiller, Gary J. , Olin, Rebecca L. , Litzow, Mark R. , Ball, Brian , Boyiadzis, Michael , Traer, Elie , Odenike, Olatoyosi , Arellano, Martha , Kovacsovics, Tibor , Collins, Robert H. , Heerema, Nyla A. , Peterson, Kevin L., Schneider, Paula A., Martycz, Molly , Gana, Theophilus J. , Rosenberg, Leonard, Marcus, Sonja, Yocum, Ashley O. , Stefanos, Mona , Borate, Uma , Burd, Amy , Byrd, John C. , Foran, James M. , Saliba, Antoine N. , Deininger, Michael , Litzow, Mark R. , Traer, Elie , Duong, Vu H , Foster, Matthew C , Mims, Alice S , Druker, Brian J , Kaufmann, Scott H , Saliba, Antoine N , Saliba, Antoine N , Byrd, John C , Stock, Wendy , Lin, Tara L. , Walker, Alison , Duong, Vu H. , Shoben, Abigail B. , Peterson, Kevin L., Chen, Timothy Frank , Levine, Ross L.
Blood Advances | October 31, 2022 | Volume: 7 | Issue: 11 | Pages: 2360-2363
